Biocompatible Nanoparticles as a Platform for Enhancing Antitumor Efficacy of Cisplatin–Tetradrine Combination

Abstract Combination therapy has been a standard strategy in the clinical tumor treatment. We have demonstrated that combination of Tetradrine (Tet) and Cisplatin (CDDP) presented a marked synergistic anticancer activity, but inevitable side effects limit their therapeutic concentration. Considering...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Fangcen Liu, Xinyue Wang, Qin Liu, Huan Zhang, Li Xie, Qin Wang, Lin Li, Rutian Li
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SpringerOpen 2021-04-01
Colecção:	Nanoscale Research Letters
Assuntos:	Copolymer Nanoparticles Combination therapy Cisplatin Tetradrine
Acesso em linha:	https://doi.org/10.1186/s11671-021-03511-4
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!